Literature DB >> 28704649

Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species Suppresses Inflammation.

Marta Wlodarska1, Chengwei Luo2, Raivo Kolde3, Eva d'Hennezel4, John W Annand4, Cortney E Heim1, Philipp Krastel5, Esther K Schmitt5, Abdifatah S Omar6, Elizabeth A Creasey3, Ashley L Garner6, Sina Mohammadi4, Daniel J O'Connell6, Sahar Abubucker4, Timothy D Arthur6, Eric A Franzosa7, Curtis Huttenhower7, Leon O Murphy4, Henry J Haiser4, Hera Vlamakis6, Jeffrey A Porter4, Ramnik J Xavier8.   

Abstract

Host factors in the intestine help select for bacteria that promote health. Certain commensals can utilize mucins as an energy source, thus promoting their colonization. However, health conditions such as inflammatory bowel disease (IBD) are associated with a reduced mucus layer, potentially leading to dysbiosis associated with this disease. We characterize the capability of commensal species to cleave and transport mucin-associated monosaccharides and identify several Clostridiales members that utilize intestinal mucins. One such mucin utilizer, Peptostreptococcus russellii, reduces susceptibility to epithelial injury in mice. Several Peptostreptococcus species contain a gene cluster enabling production of the tryptophan metabolite indoleacrylic acid (IA), which promotes intestinal epithelial barrier function and mitigates inflammatory responses. Furthermore, metagenomic analysis of human stool samples reveals that the genetic capability of microbes to utilize mucins and metabolize tryptophan is diminished in IBD patients. Our data suggest that stimulating IA production could promote anti-inflammatory responses and have therapeutic benefits.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Muc2; Peptostreptococcus; indoleacrylic acid; indolepropionic acid; mucus; organoid

Mesh:

Substances:

Year:  2017        PMID: 28704649      PMCID: PMC5672633          DOI: 10.1016/j.chom.2017.06.007

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  67 in total

1.  BLAT--the BLAST-like alignment tool.

Authors:  W James Kent
Journal:  Genome Res       Date:  2002-04       Impact factor: 9.043

2.  Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease.

Authors:  Krzysztof Fyderek; Magdalena Strus; Kinga Kowalska-Duplaga; Tomasz Gosiewski; Andrzej Wedrychowicz; Urszula Jedynak-Wasowicz; Małgorzata Sładek; Stanisław Pieczarkowski; Paweł Adamski; Piotr Kochan; Piotr B Heczko
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

3.  A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility.

Authors:  Mahesh S Desai; Anna M Seekatz; Nicole M Koropatkin; Nobuhiko Kamada; Christina A Hickey; Mathis Wolter; Nicholas A Pudlo; Sho Kitamoto; Nicolas Terrapon; Arnaud Muller; Vincent B Young; Bernard Henrissat; Paul Wilmes; Thaddeus S Stappenbeck; Gabriel Núñez; Eric C Martens
Journal:  Cell       Date:  2016-11-17       Impact factor: 41.582

4.  Characterization of a gene cluster for sialoglycoconjugate utilization in Bacteroides fragilis.

Authors:  Haruyuki Nakayama-Imaohji; Minoru Ichimura; Tomoya Iwasa; Natsumi Okada; Yoshinari Ohnishi; Tomomi Kuwahara
Journal:  J Med Invest       Date:  2012

5.  Glycan foraging in vivo by an intestine-adapted bacterial symbiont.

Authors:  Justin L Sonnenburg; Jian Xu; Douglas D Leip; Chien-Huan Chen; Benjamin P Westover; Jeremy Weatherford; Jeremy D Buhler; Jeffrey I Gordon
Journal:  Science       Date:  2005-03-25       Impact factor: 47.728

6.  Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract.

Authors:  Ivan Monteleone; Angelamaria Rizzo; Massimiliano Sarra; Giuseppe Sica; Pierpaolo Sileri; Livia Biancone; Thomas T MacDonald; Francesco Pallone; Giovanni Monteleone
Journal:  Gastroenterology       Date:  2011-04-16       Impact factor: 22.682

7.  The serine protease Pic as a virulence factor of atypical enteropathogenic Escherichia coli.

Authors:  Afonso G Abreu; Cecilia M Abe; Kamila O Nunes; Claudia T P Moraes; Lucia Chavez-Dueñas; Fernando Navarro-Garcia; Angela S Barbosa; Roxane M F Piazza; Waldir P Elias
Journal:  Gut Microbes       Date:  2016-03-10

8.  Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.

Authors:  Timothy R Sampson; Justine W Debelius; Taren Thron; Stefan Janssen; Gauri G Shastri; Zehra Esra Ilhan; Collin Challis; Catherine E Schretter; Sandra Rocha; Viviana Gradinaru; Marie-Francoise Chesselet; Ali Keshavarzian; Kathleen M Shannon; Rosa Krajmalnik-Brown; Pernilla Wittung-Stafshede; Rob Knight; Sarkis K Mazmanian
Journal:  Cell       Date:  2016-12-01       Impact factor: 41.582

Review 9.  Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis.

Authors:  Wenge Li; Tin Oo Khor; Changjiang Xu; Guoxiang Shen; Woo-Sik Jeong; Siwang Yu; Ah-Ng Kong
Journal:  Biochem Pharmacol       Date:  2008-07-23       Impact factor: 5.858

10.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

View more
  179 in total

Review 1.  Gut microbiota-derived metabolites as key actors in inflammatory bowel disease.

Authors:  Aonghus Lavelle; Harry Sokol
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-02-19       Impact factor: 46.802

2.  Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor.

Authors:  Samantha A Scott; Jingjing Fu; Pamela V Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-27       Impact factor: 11.205

Review 3.  Communication Between the Microbiota and Mammalian Immunity.

Authors:  Kyla S Ost; June L Round
Journal:  Annu Rev Microbiol       Date:  2018-06-21       Impact factor: 15.500

Review 4.  Functions of the Microbiota for the Physiology of Animal Metaorganisms.

Authors:  Daniela Esser; Janina Lange; Georgios Marinos; Michael Sieber; Lena Best; Daniela Prasse; Jay Bathia; Malte C Rühlemann; Kathrin Boersch; Cornelia Jaspers; Felix Sommer
Journal:  J Innate Immun       Date:  2018-12-19       Impact factor: 7.349

Review 5.  Therapeutic Opportunities in Inflammatory Bowel Disease: Mechanistic Dissection of Host-Microbiome Relationships.

Authors:  Damian R Plichta; Daniel B Graham; Sathish Subramanian; Ramnik J Xavier
Journal:  Cell       Date:  2019-08-22       Impact factor: 41.582

Review 6.  Host-microbiota interactions in inflammatory bowel disease.

Authors:  Roberta Caruso; Bernard C Lo; Gabriel Núñez
Journal:  Nat Rev Immunol       Date:  2020-01-31       Impact factor: 53.106

7.  Microbial metabolite indole-3-propionic acid supplementation does not protect mice from the cardiometabolic consequences of a Western diet.

Authors:  Dustin M Lee; Kayl E Ecton; S Raj J Trikha; Scott D Wrigley; Keely N Thomas; Micah L Battson; Yuren Wei; Sarah A Johnson; Tiffany L Weir; Christopher L Gentile
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-05-18       Impact factor: 4.052

8.  Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs.

Authors:  Zdenek Dvorak; Max Klapholz; Thomas P Burris; Benjamin P Willing; Antimo Gioiello; Roberto Pellicciari; Francesco Galli; John March; Stephen J O'Keefe; R Balfour Sartor; Chang H Kim; Maayan Levy; Sridhar Mani
Journal:  Mol Pharmacol       Date:  2020-08-06       Impact factor: 4.436

9.  Supplementation of Bacillus sp. DU-106 reduces hypercholesterolemia and ameliorates gut dysbiosis in high-fat diet rats.

Authors:  Jianzhao Huang; Nan Xiao; Yiying Sun; Shanshan Wu; Wenni Tian; Yujian Lai; Pan Li; Bing Du
Journal:  Appl Microbiol Biotechnol       Date:  2020-10-31       Impact factor: 4.813

Review 10.  Accessing Bioactive Natural Products from the Human Microbiome.

Authors:  Aleksandr Milshteyn; Dominic A Colosimo; Sean F Brady
Journal:  Cell Host Microbe       Date:  2018-06-13       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.